Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SOLARA ACTIVE PHARMA SCIENCES Gains 5%; BSE HEALTHCARE Index Up 0.8%
Tue, 3 Sep 11:22

SOLARA ACTIVE PHARMA SCIENCES Gains 5%; BSE HEALTHCARE Index Up 0.8%Image source: Ivcandy/www.istockphoto.com

SOLARA ACTIVE PHARMA SCIENCES share price has zoomed 5% and is presently trading at Rs 738.7.

Meanwhile, the BSE HEALTHCARE index is at 43,320.5 (up 0.8%).

Among the top gainers in the BSE HEALTHCARE index today are POLY MEDICURE (up 6.0%) and GLAND PHARMA (up 4.3%).

SUN PHARMA ADV. RES. (down 1.0%) and HIKAL CHEMIC (down 0.5%) are among the top losers today.

Over the last one year, SOLARA ACTIVE PHARMA SCIENCES has moved up from Rs 338.1 to Rs 738.7, registering a gain of Rs 400.6 (up 118.5%).

On the other hand, the BSE HEALTHCARE index has moved up from 27,871.2 to 43,320.5, registering a gain of 55.4% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were GRANULES INDIA (up 129.3%), Glenmark Pharma (up 125.8%) and SUVEN PHARMACEUTICALS (up 115.2%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 82,474.1 (down 0.1%).

The top losers among the BSE Sensex today are Bajaj Finance (down 1.9%) and Bajaj Finserv (down 1.0%). The most traded stocks in the BSE Sensex are Tata Steel and ITC.

In the meantime, NSE Nifty is at 25,256.7 (down 0.1%). Bajaj Finance and IOC are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,087.3 to 82,474.1, registering a gain of 17,386.8 points (up 26.7%).

SOLARA ACTIVE PHARMA SCIENCES Financial Update...

SOLARA ACTIVE PHARMA SCIENCES net profit grew 29.6% YoY to Rs -135 million for the quarter ended June 2024, compared to a loss of Rs 191 million a year ago. Net sales rose 3.2% to Rs 3,635 million during the period as against Rs 3,523 million in April-June 2023.

For the year ended March 2023, SOLARA ACTIVE PHARMA SCIENCES reported 61.8% increase in net profit to Rs -223 million compared to net loss of Rs 583 million during FY22. Revenue of the company grew 13.8% to Rs 14,438 million during FY23.

The current Price to earnings ratio of SOLARA ACTIVE PHARMA SCIENCES, based on rolling 12 month earnings, stands at -6.3.


Equitymaster requests your view! Post a comment on "SOLARA ACTIVE PHARMA SCIENCES Gains 5%; BSE HEALTHCARE Index Up 0.8%". Click here!